Inovio Pharmaceuticals
INO
#8785
Rank
ยฃ0.11 B
Marketcap
ยฃ1.70
Share price
-3.80%
Change (1 day)
19.15%
Change (1 year)

EPS for Inovio Pharmaceuticals (INO)

EPS in 2025 (TTM): -ยฃ2.15

According to Inovio Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -ยฃ2.14. In 2024 the company made an earnings per share (EPS) of -ยฃ2.94 an increase over its 2023 EPS that were of -ยฃ4.53.

EPS history for Inovio Pharmaceuticals from 1999 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-ยฃ2.15-26.81%
2024-ยฃ2.94-35.14%
2023-ยฃ4.53-56.62%
2022-ยฃ10.45-19.54%
2021-ยฃ12.9935.9%
2020-ยฃ9.56-11.57%
2019-ยฃ10.8115.24%
2018-ยฃ9.38-2.78%
2017-ยฃ9.646.93%
2016-ยฃ9.02134.88%
2015-ยฃ3.84-29.51%
2014-ยฃ5.45-57.34%
2013-ยฃ12.77146.55%
2012-ยฃ5.1820.83%
2011-ยฃ4.29-29.41%
2010-ยฃ6.07-48.48%
2009-ยฃ11.7910%
2008-ยฃ10.7211.11%
2007-ยฃ9.64-41.3%
2006-ยฃ16.43-66.91%
2005-ยฃ49.65110.61%
2004-ยฃ23.58-61.63%
2003-ยฃ61.44186.67%
2002-ยฃ21.43
2001N/A-100%
2000-ยฃ17.15-63.64%
1999-ยฃ47.15

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
ยฃ1.28-159.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
ยฃ7.77-462.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
-ยฃ0.93-56.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
ยฃ5.48-355.56%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
ยฃ5.65-363.67%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
ยฃ2.68-224.86%๐Ÿ‡ฌ๐Ÿ‡ง UK
Gilead Sciences
GILD
ยฃ4.85-326.39%๐Ÿ‡บ๐Ÿ‡ธ USA